Reason for request
Radiation
Arrêt du remboursement suite à un arrêt de commercialisation.
Avis favorable à l’arrêt du remboursement de la spécialité IMBRUVICA (ibrutinib) 140 mg, gélule dans les indications de l’AMM.
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
gndn3r45ALKBzT7a
Listen
